11445 related articles for article (PubMed ID: 10102620)
21. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
[TBL] [Abstract][Full Text] [Related]
22. Nevus cell aggregates massively occupying parenchyma of an external iliac lymph node: A case report and review of the literature.
Hu J; Ren M; Cai X; Zhang Y; Lv JJ; Kong YY
J Cutan Pathol; 2020 Dec; 47(12):1175-1180. PubMed ID: 32644206
[TBL] [Abstract][Full Text] [Related]
23. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
[TBL] [Abstract][Full Text] [Related]
26. Malignant blue nevus with lymph node metastases.
Zyrek-Betts J; Micale M; Lineen A; Chaudhuri PK; Keil S; Xue J; Thomas JE
J Cutan Pathol; 2008 Jul; 35(7):651-7. PubMed ID: 17976211
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
28. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
29. Myeloid leukemia-1 expression in benign and malignant melanocytic lesions.
Wong RP; Khosravi S; Martinka M; Li G
Oncol Rep; 2008 Apr; 19(4):933-7. PubMed ID: 18357378
[TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis of a benign proliferative nodule developing in a congenital melanocytic nevus in a 3-month-old infant.
Murphy MJ; Jen M; Chang MW; Grant-Kels JM; Makkar H
J Am Acad Dermatol; 2008 Sep; 59(3):518-23. PubMed ID: 18640742
[TBL] [Abstract][Full Text] [Related]
31. Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool.
Takata M; Maruo K; Kageshita T; Ikeda S; Ono T; Shirasaki F; Takehara K; Bastian BC
Hum Pathol; 2003 Jan; 34(1):89-92. PubMed ID: 12605371
[TBL] [Abstract][Full Text] [Related]
32. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
33. Nucleolin protein expression in cutaneous melanocytic lesions.
Mourmouras V; Cevenini G; Cosci E; Epistolato MC; Biagioli M; Barbagli L; Luzi P; Mannucci S; Miracco C
J Cutan Pathol; 2009 Jun; 36(6):637-46. PubMed ID: 19515042
[TBL] [Abstract][Full Text] [Related]
34. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic transvitreal fine-needle aspiration biopsy of small melanocytic choroidal tumors in nevus versus melanoma category.
Augsburger JJ; Corrêa ZM; Schneider S; Yassin RS; Robinson-Smith T; Ehya H; Trichopoulos N
Trans Am Ophthalmol Soc; 2002; 100():225-32; discussion 232-4. PubMed ID: 12545696
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
37. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
38. Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review.
Bautista NC; Cohen S; Anders KH
Am J Clin Pathol; 1994 Jul; 102(1):102-8. PubMed ID: 8037154
[TBL] [Abstract][Full Text] [Related]
39. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma.
Biddle DA; Evans HL; Kemp BL; El-Naggar AK; Harvell JD; White WL; Iskandar SS; Prieto VG
Am J Surg Pathol; 2003 May; 27(5):673-81. PubMed ID: 12717252
[TBL] [Abstract][Full Text] [Related]
40. Melanotic oncocytic metaplasia of the nasopharynx: a case report with a focus on immunohistochemical analyses and literature review.
Tajima S; Ohkubo A; Yoshida M; Koda K; Nameki I
Int J Clin Exp Pathol; 2015; 8(2):2103-10. PubMed ID: 25973111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
